The Japan Society for Ova Research (JSOR) is the certifying board for embryologists engaged in assisted reproductive technology (ART). This report summarizes the results of the qualification examinations conducted up to FY2022 and discusses the current status of embryologists in comparison with past reports. Two-thousand fifty-eight embryologists were certified out of a total of 2620 examinees, an average pass rate of 78.5%, and 34 senior embryologists were certified out of a total of 39 examinees, an average pass rate of 87.2%. The total number of certified embryologists at the end of the FY2022 review was 1509: 1478 embryologists and 31 senior embryologists. Eighty point five percent of the newly certified embryologists were female, and 72.3% were between the ages of 20–29. As for the final educational background, 76.6% of the respondents had a 4-year college degree or higher, an increase compared to the previous report. The final educational specialties were generally divided into two groups: 51.2% were from science departments other than medical technology training institutions (39.9% from agriculture, 8.1% from science, 2.6% from engineering, and 0.6% from nutrition), and 41.8% were from medical technology training institutions (qualified medical technology professionals such as clinical laboratory technicians). Compared to the previous report, there was a slight increase in the proportion of those from agricultural and science/engineering backgrounds. The number of years of clinical work experience at the time of application by the newly certified persons was 1-4 years for 78% of these applicants, no significant change from the previous report, and obstetrics and gynecology clinics accounted for 74.7% of their working facilities, an increase from the previous report. The average renewal rate for certification renewals every five years was 75.9%, and the overall certification renewal rate for certified individuals was 62.7%. Senior embryologists were certified at a rate of approximately 2.1 per year, accounting for 1.6% of the total number of embryologists and senior embryologists. With the shift of treatments such as artificial insemination to "general infertility treatment" insurance coverage, and in vitro fertilization and ICSI to “ART” from FY2022, the medical, academic, and educational communities have an even greater responsibility to work together to train quality embryologists and provide quality ART to the public. Based on the current status of embryologists certified by our society, we need to continue to implement a more appropriate embryologist certification system and strive to improve ART techniques in Japan.